AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebeler, S. E
Right arrow Articles by Clifford, A. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebeler, S. E
Right arrow Articles by Clifford, A. J
Agricola
Right arrow Articles by Ebeler, S. E
Right arrow Articles by Clifford, A. J
American Journal of Clinical Nutrition, Vol. 76, No. 4, 865-872, October 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Dietary catechin delays tumor onset in a transgenic mouse model1,2,3

Susan E Ebeler, Charles A Brenneman, Gap-Soon Kim, William T Jewell, Michael R Webb, Leticia Chacon-Rodriguez, Emily A MacDonald, Amanda C Cramer, Andrew Levi, John D Ebeler, Alma Islas-Trejo, Amber Kraus, Steven H Hinrichs and Andrew J Clifford

1 From the Departments of Viticulture and Enology (SEE, CAB, WTJ, MRW, LC-R, EAM, ACC, AL, and JDE), Nutrition (G-SK and AJC), and Animal Science (AI-T), University of California, Davis, and the Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha (AK and SHH).

Background: Evidence exists that red wine, which contains a large array of polyphenols, is protective against cardiovascular disease and possibly cancer.

Objective: We tested the hypothesis that catechin, the major monomeric polyphenol in red wine, can delay tumor onset in transgenic mice that spontaneously develop tumors.

Design: Mice were fed a nutritionally complete amino acid–based diet supplemented with (+)-catechin (0–8 mmol/kg diet) or alcohol-free solids from red wine. Mice were examined daily; the age at which a first tumor appeared was recorded as the age at tumor onset. Plasma catechin and metabolite concentrations were quantified at the end of the study.

Results: Dietary catechin significantly delayed tumor onset; a positive, linear relation was observed between the age at tumor onset and either the amount of dietary catechin (r2 = 0.761, P < 0.001) or plasma catechin and metabolite concentrations (r2 = 0.408, P = 0.003). No significant effects on tumor onset were observed when mice consumed a diet supplemented with wine solids containing <0.22 mmol catechin/kg diet, whereas a previous study showed that wine solids with a similar total polyphenol concentration but containing {approx}4 times more catechin significantly delayed tumor onset by {approx}30 d compared with a control diet. The catechin composition of the wines is directly related to processing conditions during vinification.

Conclusions: Physiologic intakes of specific dietary polyphenols, such as catechin, may play an important role in cancer chemoprevention. Wines have different polyphenol concentrations and compositions; therefore, the overall health benefits of individual wines differ.

Key Words: Amino acid–based diet • transgenic mice • catechin • cancer • tumor onset • wine




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition